Page 13 - புஜிஃபில்ம் ஹோல்டிங்ஸ் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Global Vaccines Top 202 Million; Russia Cases Slow: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Global Vaccines Top 202 Million; Italy Strategy: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Global Vaccines Top 202 Million; Italy Strategy: Virus Update
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Fujifilm to restart clinical trial of Avigan to treat COVID-19: media
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Article content
TOKYO A study of global trials of Fujifilm Holdings Corp’s antiviral drug Avigan suggests it has little benefit for COVID-19 patients once their symptoms become serious.
The meta-analysis of nine clinical trials showed the drug, known generically as favipiravir, helped patients early on in their hospitalization, according to the preprint of a study posted Wednesday on the medical website medRxiv.
We apologize, but this video has failed to load.
Try refreshing your browser, or Fujifilm s Avigan shows no significant benefit on COVID-19 mortality - study Back to video
But it failed to demonstrate statistically significant results in reducing mortality among those with mild to moderate COVID-19.